Clinical Trial Update: Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers [Phase 2, Phase 3]

View source ↗

Summary

Immunogenicity results from Phase 2 and Phase 3 trials of a combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) vaccine in healthy toddlers, spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis

Drugs mentioned

• DTaP vaccine (diphtheria-tetanus-recombinant acellular pertussis) (Diphtheria, Tetanus, and Acellular Pertussis (DTaP) vaccine)

Snippet

Sponsor: BioNet-Asia Co., Ltd. | Conditions: Pertussis Whooping Cough | Phase 2, Phase 3 | Status: COMPLETED